Company Filing History:
Years Active: 2025
Title: Pierre Sacre: Innovator in Pharmaceutical Technology
Introduction
Pierre Sacre is a notable inventor based in Maizeret, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release drug delivery systems. His innovative approach has the potential to enhance the efficacy of medications and improve patient outcomes.
Latest Patents
Pierre Sacre holds a patent for "Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form." This invention involves a controlled-release multilayer microparticle designed for oral administration or direct administration in the stomach. The microparticle consists of a core that includes a pharmaceutically active compound, which may be pramipexole, along with a controlled-release intermediate coating layer and an outer protection coating layer. The external protection layer is composed of a hydrophilic gastro-soluble component and a hydrophobic or insoluble component. This patent also encompasses a liquid pharmaceutical composition containing the microparticles, a kit for preparing the liquid composition, and methods for treating diseases with the composition.
Career Highlights
Pierre Sacre is associated with Be Pharbel Manufacturing, where he applies his expertise in pharmaceutical innovations. His work focuses on developing advanced drug delivery systems that can significantly improve the therapeutic effects of medications. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.
Collaborations
Pierre collaborates with talented professionals in his field, including Geoffrey De Bilde and Jonathan Goole. These partnerships enhance the innovative capacity of his projects and contribute to the advancement of pharmaceutical technologies.
Conclusion
Pierre Sacre's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to improving drug delivery systems. His work has the potential to make a significant impact on patient care and treatment efficacy.